Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.

@article{Kastrati2006PredictiveFO,
  title={Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.},
  author={Adnan Kastrati and Alban Dibra and Julinda Mehilli and Sandra C. Mayer and Susanne Pinieck and J{\"u}rgen Pache and Josef Dirschinger and Albert Schoemig},
  journal={Circulation},
  year={2006},
  volume={113 19},
  pages={2293-300}
}
BACKGROUND The efficacy of drug-eluting stents in reducing restenosis risk has not been uniform across patient subsets. Identifying predictive factors of restenosis may help improve outcomes after percutaneous coronary interventions. METHODS AND RESULTS All patients who underwent successful implantation of sirolimus- or paclitaxel-eluting stents in native vessels for de novo lesions between August 2002 and December 2004 were eligible for this study. All data were prospectively collected… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 115 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Drug - eluting stents for complex lesions : randomized rapamycin versus paclitaxel CORPAL study

  • AT Ong, PW Serruys, +13 authors RT vanDomburg
  • J Am Coll Cardiol
  • 2005

Drugeluting stents for complex lesions: randomized rapamycin versus paclitaxel

  • J de Lezo, A Medina, +9 authors F. Melian
  • CORPAL study. J Am Coll Cardiol. 2005;45:75A…
  • 2005

Eight-month outcome of the Reality Study: a prospective, randomized, multi-center head-to-head comparison of the sirolimuseluting stent (Cypher) and the paclitaxel-eluting stent (Taxus)

  • MC Morice
  • Paper presented at: Scientific Session of the…
  • 2005

Similar Papers

Loading similar papers…